A PRK-armed oncolytic adenovirus drives calreticulin exposure for dendritic cell licensing to prime antitumor CD8⁺ T cells and synergizes with anti-PD-1 or CAR-T therapy in colorectal cancer.
- DOI
- 10.1007/s00535-026-02513-2
- Published
- 2026 Sep 7
- Container
- Journal of gastroenterology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00535-026-02513-2,
title = {A PRK-armed oncolytic adenovirus drives calreticulin exposure for dendritic cell licensing to prime antitumor CD8⁺ T cells and synergizes with anti-PD-1 or CAR-T therapy in colorectal cancer.},
author = {Liu Y and Ran B and Kong L and Zhou D and Zhuang Y and Guo C and Ren X and Li J and Yang X and Cui H and Xin Q and Xiao L and Gu X and Wu J and Jiang C},
year = {2026},
journal = {Journal of gastroenterology},
doi = {10.1007/s00535-026-02513-2},
url = {https://doi.org/10.1007/s00535-026-02513-2}
}RIS
TY - JOUR TI - A PRK-armed oncolytic adenovirus drives calreticulin exposure for dendritic cell licensing to prime antitumor CD8⁺ T cells and synergizes with anti-PD-1 or CAR-T therapy in colorectal cancer. AU - Liu Y AU - Ran B AU - Kong L AU - Zhou D AU - Zhuang Y AU - Guo C AU - Ren X AU - Li J AU - Yang X AU - Cui H AU - Xin Q AU - Xiao L AU - Gu X AU - Wu J AU - Jiang C PY - 2026 JO - Journal of gastroenterology DO - 10.1007/s00535-026-02513-2 UR - https://doi.org/10.1007/s00535-026-02513-2 ER -
APA
Y, L., B, R., L, K., D, Z., Y, Z., C, G., X, R., J, L., X, Y., H, C., Q, X., L, X., X, G., J, W., & C, J. (2026). A PRK-armed oncolytic adenovirus drives calreticulin exposure for dendritic cell licensing to prime antitumor CD8⁺ T cells and synergizes with anti-PD-1 or CAR-T therapy in colorectal cancer.. Journal of gastroenterology. https://doi.org/10.1007/s00535-026-02513-2
Source records
- pubmed · retrieved 2026-09-25T15:33:14.803Z